Literature DB >> 12616016

MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease.

Till R Bader1, Kimberly L Beavers, Richard C Semelka.   

Abstract

PURPOSE: To evaluate the spectrum of magnetic resonance (MR) imaging appearances of the liver in primary sclerosing cholangitis (PSC) and to examine their correlation with clinical stage of disease.
MATERIALS AND METHODS: Fifty-two patients (25 female, 27 male; mean age, 43 years; age range, 11-87 years) with PSC underwent nonenhanced and gadolinium-enhanced MR imaging. Two abdominal radiologists retrospectively reviewed all images (independently and then in consensus) for the imaging pattern of the liver parenchyma, presence and grade of intrahepatic biliary ductal dilatation, and presence of areas of parenchymal atrophy or abnormal signal intensity and/or gadolinium enhancement. Imaging findings were correlated with Child class, Child-Turcotte-Pugh score, and Mayo end-stage liver disease (MELD) score. Statistical analyses (kappa scoring for interobserver agreement, McNemar test, Mann-Whitney U test, multiple regression analysis, Spearman correlation) were performed.
RESULTS: Of 52 patients, seven (13%) had no imaging findings of cirrhosis, 17 (33%) had a diffuse pattern of cirrhosis, and 28 (54%) had a large macronodular pattern (with nodules >or=3 cm) (kappa = 0.84). Intrahepatic biliary ductal dilatation was observed in 44 (85%) patients and was general in 18 (35%) and segmental in 26 (50%). Peripheral wedge-shaped areas of parenchyma were observed with atrophy in 23 (44%) and 25 (48%) patients by the two readers (kappa = 0.76) and without atrophy in 18 (35%) patients by both readers (kappa = 1.00). No correlation was found between imaging findings and clinical scores (P >.05, multiple regression analysis; P =.25-.75, Mann-Whitney U test; Spearman correlation coefficients between -0.33 and 0.33).
CONCLUSION: The spectrum of MR imaging appearances of PSC is diverse and comprises distinct patterns that do not appear to correlate with severity of disease. Large regenerative nodules are a frequent finding and may help to establish the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616016     DOI: 10.1148/radiol.2263011623

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 2.  [Value of radiological methods in the diagnosis of biliary diseases].

Authors:  J E W Zajaczek; M Keberle
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

3.  MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.

Authors:  Candice A Bookwalter; Sudhakar K Venkatesh; John E Eaton; Thomas D Smyrk; Richard L Ehman
Journal:  Abdom Radiol (NY)       Date:  2018-12

Review 4.  [Inflammatory diseases of the gall bladder and biliary system. II. Acute and chronic inflammation of the biliary system--primary biliary cirrhosis].

Authors:  H Helmberger; B Kammer
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 5.  [Inflammatory diseases of the gall bladder and biliary system. I. Imaging--cholelithasis--inflammation of the gall bladder].

Authors:  H Helmberger; B Kammer
Journal:  Radiologe       Date:  2005-05       Impact factor: 0.635

6.  Altered liver morphology after portal vein thrombosis: not always cirrhosis.

Authors:  Mitchell E Tublin; Alexander J Towbin; Michael P Federle; Michael A Nalesnik
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

7.  Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.

Authors:  Bojan D Petrovic; Paul Nikolaidis; Nancy A Hammond; John A Martin; Polina V Petrovic; Pankaja M Desai; Frank H Miller
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

8.  Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography.

Authors:  Rolf Reiter; Mehrgan Shahryari; Heiko Tzschätzsch; Dieter Klatt; Britta Siegmund; Bernd Hamm; Jürgen Braun; Ingolf Sack; Patrick Asbach
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

9.  Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.

Authors:  Sudhakar K Venkatesh; Christopher L Welle; Frank H Miller; Kartik Jhaveri; Kristina I Ringe; John E Eaton; Helen Bungay; Lionel Arrivé; Ahmed Ba-Ssalamah; Aristeidis Grigoriadis; Christoph Schramm; Ann S Fulcher
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

Review 10.  Fibrotic Events in the Progression of Cholestatic Liver Disease.

Authors:  Hanghang Wu; Chaobo Chen; Siham Ziani; Leonard J Nelson; Matías A Ávila; Yulia A Nevzorova; Francisco Javier Cubero
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.